Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins

Research output: Contribution to journalJournal articleResearchpeer-review

  1. How a Medical Association Can Make a Difference in a Crisis Situation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The EHA Research Roadmap: Malignant Lymphoid Diseases

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies

    Research output: Contribution to journalLetterpeer-review

  2. How a Medical Association Can Make a Difference in a Crisis Situation

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Structural variations in cancer and the 3D genome

    Research output: Contribution to journalReviewpeer-review

  4. Family caregiver ambassador support for caregivers of patients with newly diagnosed hematological cancer: a feasibility study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Clonal hematopoiesis of indeterminate potential (CHIP) is common in the elderly and has been reported to associate with accelerated epigenetic age (AgeAccel), especially intrinsic (ie, cell-type independent) AgeAccel and to a lesser degree extrinsic AgeAccel, which reflects the immune-cell composition of the peripheral blood. We investigated the association between CHIP occurrence and AgeAccel in 154 Danish twin pairs aged 73-90 years (mean 79), using both individual-level and intrapair analyses, the latter to control for shared genetic and environmental factors. Of 308 individuals, 116 carried a CHIP mutation. CHIP carriers had non-significantly increased AgeAccel compared with non-carriers; the strongest association was for the Intrinsic Epigenetic Age Acceleration (IEAA) estimator (CHIP carriers 1.4 years older, P = 0.052). In intrapair analyses, the extrinsic Hannum age estimator showed the strongest association (1.6 years older, P = 0.027). In mutation-specific analyses, TET2 mutations were associated with the extrinsic Hannum age estimator in both individual-level (3.0 years older, P = 0.003) and intrapair analyses (2.8 years older, P = 0.05). DNMT3A mutations were associated with IEAA in individual-level (1.9 years older, P = 0.034) but not intrapair analysis (0.9 years, P = 0.41). Analyses of logit-transformed variant allele frequency were generally consistent with these results. Together, these observations indicate that different factors may be driving the expansion of DNMT3A and TET2 clones, respectively. Finally, CHIP carriers accelerated in both the Hannum and the GrimAge age estimators did not have an increased mortality risk in our cohort followed for 22 years (HR = 1.02, P = 0.93), hence not replicating the stratification model proposed by Nachun et al.

Original languageEnglish
JournalHemaSphere
Volume6
Issue number9
Pages (from-to)e768
ISSN2572-9241
DOIs
Publication statusPublished - Sep 2022

Bibliographical note

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.

ID: 84213624